Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Biomarkers for the Prediction of Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia

NCT04619693 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04619693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04619693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Biomarkers for the Prediction of Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Terminated
Start date
November 18, 2020
Completion date
October 6, 2021
Enrollment
79 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia, viral, sars-cov-2